Bupropion for the Treatment of Methamphetamine Dependence

Cited by (234)

Items 201–234 of 234

1. A new protocol of methamphetamine dependence treatment with taper-up-off treatment of opium tincture, a new hope to cure the methamphetamine addiction
   Hossein Dezhakam, Amin Dezhakam, Shani Dezhakam, Ani Dezhakam, Arvin Haghighatfard · 2023 · Research Square
2. Recent Advances in Drug Development
   Frank J. Vocci · 2014 · Springer eBooks
3. Addiction to Amphetamines and Methamphetamines
   Ahmed Elkashef · 2014 · Springer eBooks
4. Pharmacological Treatment for Methamphetamine Dependence
   Brinn E. Culver · 2014 · Research Exchange (Washington State University)
5. Methamphetamine withdrawal: clinical profile, assessment and treatment
   Christopher Cruickshank · 2010 · UWA Profiles and Research Repository (UWA)
6. Evidence-Based Practices for Co-occurring Chemical Dependency and Mental Illness
   Christine Yuodelis‐Flores, Richard K. Ries, W. Murray Bennett · 2012 · Springer eBooks
7. Pharmacotherapies for Drug Addiction
   Cassandra D. Gipson, Peter W. Kalivas · 2012 · Royal Society of Chemistry eBooks
8. Linear-rank testing of a non-binary, responder-analysis, efficacy score to evaluate pharmacotherapies for substance use disorders
   Tyson H. Holmes, Shou-Hua Li, David J. McCann · 2016 · Statistical Methods in Medical Research
9. Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China
   Hongqiang Sun, Hongmei Chen, Fude Yang, Lin Lü, Thomas R. Kosten · 2013 · American Journal on Addictions
10. z¿gPc ≤¿ØZd†ØM ZdØ z) µuY∫≥Zs Z∑ ∂)µv¥¥ß ∂òkYzر YyZ∞¿)π ©Zyu± Yz∏cz∏É uZ¿dóY±Z Øyu|ßYz Ø ÊËÓÊ
    Ø Zd, ß Yz · 2016
11. Targeting the trace amine-associated receptor 1 in psychomotor stimulant addiction.
    Yue Pei · 2016 · UC Research Repository (University of Canterbury)
12. Treatment of Methamphetamine withdrawal in trauma patients
    Phillips B, Snyder S, Safa H, Wu J, Muhammad Mehmood Shahid, Lauren M. Turco, Schroeder A, Weber W, Juan Antonio Asensio · 2017 · Integrative Clinical Medicine
13. Deprescribing Benzodiazepines, Z-Drugs, and Stimulants
    Swapnil Gupta, Rebecca A. Miller, John Daniel Cahill · 2019
14. Pharmacotherapy of Addiction to Amphetamine-Type Stimulants
    Ahmed M. Elkashef, Jag H. Khalsa · 2020 · Springer eBooks
15. Amphetamin
    Felicitas Ernst, Leonard Viohl, Felix Betzler · 2020 · Springer Reference Psychologie
16. References
    Brian S. Fulton · 2014 · Wiley eBooks
17. Attention Deficit/Hyperactivity Disorder and Substance Abuse
    F. Levin · 2015 · Springer eBooks
18. A New Protocol of Methamphetamine Dependence Treatment with Taper-Up-Off Treatment of Opium Tincture, a New Hope to Cure the Methamphetamine Addiction
    2023 · International Journal of Psychiatry
19. Disorders Due to Substance Use: Stimulants
    Kevin A. Sevarino, Michael Farrell · 2023 · Springer eBooks
20. Chapter 54. Treatment of Substance Use Disorders
    Brian J. Sherman, Karen J. Hartwell, Aimee L. McRae‐Clark, Alexandra Herron, Kathleen T. Brady · 2024 · American Psychiatric Association Publishing eBooks
21. Emerging Therapeutic Applications for Treating Methamphetamine Use Disorder
    Tuanthon Boonlue · 2025 · IntechOpen eBooks
22. Baseline Moderators of Response to Naltrexone and Bupropion in the Treatment of Methamphetamine Use Disorder: An ADAPT-2 Study
    Thomas James Carmody, Taryn L. Mayes, Manish K. Jha, STEVEN J. SHOPTAW, Madhukar H. Trivedi · 2025 · Journal of Addiction Medicine
23. ‘Crystal Meth’ Use in an Addiction Outpatient Clinic in Italy: A Multifaceted Challenge
    Filippo Besana, Stefano Pasquariello, Attilio Negri, Valentina Costa · 2025 · Psychoactives
24. Amphetamine und Crystal Meth: Epidemiologie, Symptomatik und Therapie konsumassoziierter Störungen
    B. Quednow, Kenneth M. Dürsteler · 2022 · Suchttherapie
25. Pharmacotherapy for Stimulant Use Disorders
    David Hankins · 2025 · Springer eBooks
26. Chapter 6. Stimulants
    Kyle Matthew Kampman · 2025 · American Psychiatric Association Publishing eBooks
27. Disruption of Dopamine Homeostasis by Psychostimulants
    Juan Torres, Colton Bredenkamp, Atzin Vazquez, Ernest T. Chivero · 2026 · Molecular Neurobiology
28. Amphetamines revisited with focus on current pharmacology, cognitive effects, and treatment strategies
    Jaya Kumar, Igor Iezhitsa, R. Agarwal · 2026 · Discover Neuroscience
29. Mediators of Treatment Response in Clinical Trial of Naltrexone and Bupropion for Methamphetamine Use Disorder: A Longitudinal Mediation Analysis
    Ramin Mojtabai, Ryoko Susukida, Mehdi Farokhnia, Trang Quynh Nguyen, Lorenzo Leggio, Cecilia L. Bergeria, Smita Prasad, Kelly E. Dunn, Masoumeh Amin‐Esmaeili · 2026 · medRxiv
30. Chapter 9. Stimulant Use Disorder Among Older Adults
    Margaret Z. Wang, Jonathan Buchholz, Andrew J. Saxon · 2024 · American Psychiatric Association Publishing eBooks
31. Evaluating Reduced Use and Abstinence as Outcomes in Pharmacotherapy Trials for Stimulant Use Disorder
    Masoumeh Amin‐Esmaeili, Mehdi Farokhnia, Ramin Mojtabai, Lorenzo Leggio, Reneé M. Johnson, Ryoko Susukida · 2026 · JAMA Psychiatry
32. Mediators of treatment response in a clinical trial of naltrexone and bupropion for methamphetamine use disorder: A longitudinal mediation analysis
    Ramin Mojtabai, Ryoko Susukida, Mehdi Farokhnia, Trang Quynh Nguyen, Lorenzo Leggio, Cecilia L. Bergeria, Smita Prasad, Kelly E. Dunn, Masoumeh Amin‐Esmaeili · 2026 · Journal of Psychopharmacology
33. Patient and Provider Demand for and Readiness to Adopt Medications for Stimulant Use Disorders in Real‐World Settings: Pre‐Planning Toward Accelerated Implementation
    Enya B. Vroom, Erin P. Finley, Carma Deem Bolton, Tara Karns-Wright, Jennifer Sharpe Potter · 2026 · Drug and Alcohol Review
34. BindingDB Entry 50034477: (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).
    BindingDB · 2012 · UC San Diego